Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the treatment of obesity. This medication works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://liviabrwg017806.thezenweb.com/trelaglutide-exploring-a-new-therapy-for-chronic-diseases-77362935